tirzepatide discontinued being FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease We have temporarily discontinued offering

Retatrutide side effects from TRIUMPH-4 Phase 3 trial data, including the novel dysesthesia signal Common Side Effects (from TRIUMPH-4 Phase 3) Source: Eli Lilly press release and medical information portal (medical.lilly.com), December 11, 2025

We also appreciate the potent formulation of health-boosting ingredients, which includes 1500mg of L-Glutathione, Vitamin C, Aloe Vera Oil, and Hyaluronic Acid

Competing Interests Not applicable

When combined, these treatments help contour your body and improve cellulite for a smoother, firmer look--without surgery or recovery time

It is also popular in cleansing products as it helps to thicken them up and has some refatting and skin-smoothing effect